https://doi.org/10.1016/s1470-2045(17)30715-5
O
Oliver Tomé
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
988
Citations
11
h-index
11
i10-index
Oliver Tomé is an academic researcher from German Cancer Society. The author has contributed to research in topics: PARP inhibition in cancer therapy & Ovarian cancer diagnosis and treatment & BRCA gene mutations in cancer. The author has an h-index of 11, co-authored 60 publications.
Papers by this author
worksExtended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
2017 · The Lancet Oncology · 120 citations
Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer
2022 · JAMA Oncology · 20 citations
https://doi.org/10.1001/jamaoncol.2022.1059
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)
2016 · Journal of Cancer Research and Clinical Oncology · 16 citations
https://doi.org/10.1007/s00432-016-2307-0
First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study
2021 · The Breast · 6 citations
https://doi.org/10.1016/j.breast.2021.08.014
Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effects
2025 · EBioMedicine · 3 citations
https://doi.org/10.1016/j.ebiom.2025.105764
Gene Expression And Patient-Reported Outcomes Reveal Links Between Circadian Rhythm Disruption And PARP Inhibitor Toxicity In Ovarian Cancer Patients
2025 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2024.101460
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat